AquaBounty Technologies Inc (AQB)

AquaBounty announced its second-quarter fiscal 2025 financial results on August 5, 2025, reporting a net loss of $3.4 million, an improvement from a $50.5 million loss in Q2 2024. The stock experienced a notable upswing on August 28, 2025, surging by 66.85% after a dip. The company regained compliance with Nasdaq's minimum bid price requirement on September 17, 2025. AquaBounty Technologies announced its third-quarter 2025 financial results on October 28, 2025. The stock price has generally been in a falling trend in the short term, and negative signals from moving averages suggest a weak performance in the near term.

Given AquaBounty Technologies, Inc. ceased all fish farming operations in December 2024, the concept of demand seasonality for its products is no longer directly applicable to its current business model. The company's current focus is on monetizing its intellectual property and physical assets.

AquaBounty Technologies, Inc. has transitioned from a biotechnology and aquaculture company focused on genetically modified fish production to one primarily focused on monetizing its intellectual property and physical assets. Founded in 1991, AquaBounty is known for AquAdvantage Salmon, a bioengineered Atlantic salmon that reaches market size faster than conventional salmon. In late 2024, AquaBounty ceased all fish farming operations due to liquidity constraints and is now concentrating on the strategic disposition of its assets.

AquaBounty Technologies, Inc. is headquartered in Maynard, Massachusetts, United States. Historically, the company operated land-based recirculating aquaculture system (RAS) farms in Albany, Indiana, and two Canadian farm sites in Bay Fortune and Rollo Bay, Prince Edward Island. The Indiana farm was sold in July 2024, and the Canadian hatchery operations were wound down in December 2024. A large-scale production facility was under construction in Pioneer, Ohio, but this project has been put on hold due to financial issues, and related assets are being sold. Sales of AquAdvantage salmon were previously approved in Canada and the United States.

AquaBounty Technologies has faced challenges with its brand reputation, particularly concerning consumer and retailer acceptance of its genetically engineered AquAdvantage Salmon. There has been "little demand" for the product, and "consumers and retailers rejected the GM salmon." This lack of market acceptance led to the company's decision to cease all fish farming operations in December 2024.

AquaBounty Technologies, Inc. has 33 institutional owners and shareholders holding a total of 424,192 shares, including DRW Securities, LLC, Epiq Partners, Llc, and BlackRock, Inc. Key individual insiders with significant holdings include Randal J. Kirk, Alana Kirk, and Sylvia Wulf. Insider ownership is notably high at 2,493.66%, while institutional ownership stands at 10.93%.